UBS ASSET MANAGEMENT AMERICAS LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 184 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$205,8250.0%7,2550.0%0.00%
Q1 2023$205,825
-9.7%
7,255
-7.0%
0.00%
Q4 2022$227,965
-99.9%
7,7990.0%0.00%
Q3 2022$206,049,000
-64.2%
7,799
-39.7%
0.00%
Q2 2022$575,013,000
-13.5%
12,942
-3.6%
0.00%
Q1 2022$664,452,000
+8.9%
13,426
+12.0%
0.00%
Q4 2021$610,174,000
-7.1%
11,983
+1.8%
0.00%
Q3 2021$656,643,000
+135.0%
11,772
+80.3%
0.00%
Q2 2021$279,441,000
+2.5%
6,5290.0%0.00%
Q1 2021$272,521,000
-10.4%
6,5290.0%0.00%
Q4 2020$304,056,000
+9.6%
6,5290.0%0.00%
Q3 2020$277,351,000
-11.5%
6,5290.0%0.00%
Q2 2020$313,261,000
+6.4%
6,529
+2.0%
0.00%
Q1 2020$294,446,000
-51.5%
6,401
-36.7%
0.00%
Q4 2019$607,710,000
+60.3%
10,115
+50.9%
0.00%
Q3 2019$379,076,000
+1.6%
6,7010.0%0.00%
Q2 2019$373,112,000
+10.3%
6,7010.0%0.00%
Q1 2019$338,333,000
+58.4%
6,701
+26.4%
0.00%
Q4 2018$213,537,000
-41.9%
5,3000.0%0.00%
Q3 2018$367,449,000
-8.4%
5,3000.0%0.00%
Q2 2018$400,998,000
+163572.7%
5,300
+51.4%
0.00%
Q3 2016$245,000
-29.2%
3,500
-10.3%
0.00%
Q4 2015$346,000
+19.7%
3,9000.0%0.00%
Q3 2015$289,000
+2.1%
3,900
+11.4%
0.00%
Q2 2015$283,0003,5000.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders